NeuroPace(NPCE) - 2023 Q2 - Earnings Call Presentation

Second quarter 2023 revenue of $16.5 million increased 62% year-over-year MOUNTAIN VIEW, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today reported financial results for the second quarter ended June 30, 2023. Recent Highlights Second Quarter 2023 Financial Results Full Year 2023 Financial Guidance Based in Mountain View, Calif., NeuroPace is a commercial-stage medical de ...